AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 275: E763-E769, 1998;
0193-1849/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGuinness, O. P.
Right arrow Articles by Lacy, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGuinness, O. P.
Right arrow Articles by Lacy, D. B.
Vol. 275, Issue 5, E763-E769, November 1998

Hepatic and muscle glucose metabolism during total parenteral nutrition: impact of infection

Owen P. McGuinness, Christine Donmoyer, Joseph Ejiofor, Suzanne McElligott, and D. Brooks Lacy

Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232-0615

We examined the impact of infection on hepatic and muscle glucose metabolism in dogs adapted to chronic total parenteral nutrition (TPN). Studies were done in five conscious chronically catheterized dogs, in which sampling (artery, portal and hepatic vein, and iliac vein), infusion catheters (inferior vena cava), and Transonic flow probes (hepatic artery, portal vein, and iliac artery) were implanted. Fourteen days after surgery, dogs were placed on TPN. After 5 days of TPN, an infection was induced, and the TPN was continued. The balance of substrates across the liver and limb was assessed on the day before infection (day 0) and 18 (day 1) and 42 h (day 2) after infection. On day 0, the liver was a marked net consumer of glucose (4.3 ± 0.6 mg · kg-1 · min-1) despite near normoglycemia (117 ± 5 mg/dl) and only mild hyperinsulinemia (16 ± 2 µU/ml). In addition, the majority (79 ± 13%) of the glucose taken up by the liver was released as lactate (34 ± 6 µmol · kg-1 · min-1). After infection, net hepatic glucose uptake decreased markedly on day 1 (1.6 ± 0.9 mg · kg-1 · min-1) and remained suppressed on day 2 (2.4 ± 0.5 mg · kg-1 · min-1). Net hepatic lactate output also decreased on days 1 and 2 (15 ± 5 and 12 ± 3 µmol · kg-1 · min-1, respectively). This occurred despite increases in arterial plasma glucose on days 1 and 2 (135 ± 9 and 144 ± 9 mg/dl, respectively) and insulin levels on days 1 and 2 (57 ± 14 and 34 ± 9 µU/ml, respectively). In summary, the liver undergoes a profound adaptation to TPN, making it a major site of glucose disposal and conversion to lactate. Infection impairs hepatic glucose uptake, forcing TPN-derived glucose to be removed by peripheral tissues.

liver blood flow; lactate; intestine


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. C. Moore, C. A. DiCostanzo, M. S. Smith, B. Farmer, T. D. Rodewald, D. W. Neal, P. E. Williams, and A. D. Cherrington
Hepatic portal venous delivery of a nitric oxide synthase inhibitor enhances net hepatic glucose uptake
Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E768 - E777.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S.-S. Chen, C. J. Torres-Sanchez, N. Hosein, Y. Zhang, D. B. Lacy, and O. P. McGuinness
Time course of the hepatic adaptation to TPN: interaction with glycogen depletion
Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E163 - E170.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S.-S. Chen, C. M. Donmoyer, D. A. Pearson, A. Poole, Y. Zhang, D. B. Lacy, and O. P. McGuinness
Impact of infection on glucose-dependent liver glucose uptake during TPN: interaction with insulin
Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E286 - E295.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. M. Donmoyer, S.-S. Chen, D. B. Lacy, D. A. Pearson, A. Poole, Y. Zhang, and O. P. McGuinness
Infection impairs insulin-dependent hepatic glucose uptake during total parenteral nutrition
Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E574 - E582.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. M. Donmoyer, D. B. Lacy, Y. Zhang, S.-S. Chen, and O. P. McGuinness
Impact of chronic fructose infusion on hepatic metabolism during TPN administration
Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1151 - E1158.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. M. Donmoyer, J. Ejiofor, D. B. Lacy, S.-S. Chen, and O. P. McGuinness
Fructose augments infection-impaired net hepatic glucose uptake during TPN administration
Am J Physiol Endocrinol Metab, May 1, 2001; 280(5): E703 - E711.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. M. Donmoyer, S.-S. Chen, S. A. Hande, D. B. Lacy, J. Ejiofor, and O. P. McGuinness
Hyperinsulinemia compensates for infection-induced impairment in net hepatic glucose uptake during TPN
Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E235 - E243.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. Shiota, P. Jackson, P. Galassetti, M. Scott, D. W. Neal, and A. D. Cherrington
Combined intraportal infusion of acetylcholine and adrenergic blockers augments net hepatic glucose uptake
Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E544 - E552.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online